Newsbot

Why AMD Stock Rose Today

The tech stock is a buy ahead of its upcoming earnings report, according to one Wall Street analyst.

Nvidia stock gets major reality check on $100B number

Theres no denying it: Nvidia (NVDA) is priced for perfection. Regardless of your personal opinion, the standard mega-cap argument is no longer valid, with the tech giant now firmly in the perpetual AI capex machine space. This means any issues with OpenAI will lead to a sharp hit in the sentiment. ...

Elon Musk legt seine Firmen SpaceX und xAI zusammen

Es ist eine Fusion der Superlative: Das Raumfahrtunternehmen SpaceX hat den KI-Entwickler xAI übernommen. Elon Musk kann somit viel frisches Geld in die KI-Sparte pumpen - und denkt laut über Rechenzentren im All nach.

Federal Reserve official blasts latest interest-rate pause

The Federal Reserve’s pause on interest-rate cuts in January — and its potential impact on your wallet — was expected by economists and markets.  But, in its wake, not everyone agrees it was an appropriate monetary policy step for the U.S. economy. The Federal Open Market Committee voted 10-2 ...

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

S&P 500 Prepares for Breakout

Market Analysis by covering: S&P 500, Dow Jones Industrial Average, US Small Cap 2000, iShares Russell 2000 ETF. Read s Market Analysis on Investing.com

Abbott Labs CEO makes $2M bet as stock sinks

Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott Laboratories, spent his own personal capital to buy his own company’s shares on the open market. A straight ...